+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
GLAXO

GlaxoSmithKline Pharmaceuticals Share Price

₹2,515.10 +17.1 (0.68%)

29 Oct, 2026 3:32 PM (IST)

GlaxoSmithKline Pharmaceuticals live price: ₹2,515.10. It opened at ₹2,498 vs previous close ₹2,498; intraday high/low: ₹2,540/₹2,495. The 50 & 200 DMA stand at ₹2,646.10/₹2,592.20.

GlaxoSmithKline Pharmaceuticals Performance

  • Today's Low
  • ₹2,495
  • Today's High
  • ₹2,540
  • 52 Week Low
  • ₹2,088
  • 52 Week High
  • ₹3,121
  • Open Price₹2,498
  • Previous Close₹2,498
  • Volume43,495
  • 50 DMA₹2,646.10
  • 100 DMA₹2,625.70
  • 200 DMA₹2,592.20

GlaxoSmithKline Pharmaceuticals Chart

Investment Returns

  • Over 1 Month -13.16%
  • Over 3 Month -4.46%
  • Over 6 Month + 4.35%
  • Over 1 Year -5.38%

Smart Investing Starts Here Start SIP with GlaxoSmithKline Pharmaceuticals for Steady Growth!

Invest Now

GlaxoSmithKline Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 39.9
  • PEG Ratio
  • 3.2
  • Market Cap Cr
  • 42,607
  • P/B Ratio
  • 17
  • Average True Range
  • 72.7
  • EPS
  • 63.1
  • Dividend Yield
  • 2.3
  • MACD Signal
  • -82.4
  • RSI
  • 40.6
  • MFI
  • 55.7

Latest Stock News Updates

GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

As per attachment

GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Board Meeting Intimation for To Consider, Approve And Take On Record The Un-Audited Financial Results For The Second Quarter & Half Year Ended 30Th September 2026.

Glaxosmithkline Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve As per attachment

GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

As per attachment

GlaxoSmithKline Pharmaceuticals Financials

GlaxoSmithKline Pharmaceuticals Technicals

EMA & SMA

Current Price
₹2,515.10
+ 17.1 (0.68%)
pointer
  • Bearish Moving Average 10
  • Bullish Moving Average 6
  • 20 Day
  • ₹2,560.40
  • 50 Day
  • ₹2,646.10
  • 100 Day
  • ₹2,625.70
  • 200 Day
  • ₹2,592.20

Resistance and Support

2516.7 Pivot Speed
  • R3 2,583.40
  • R2 2,561.70
  • R1 2,538.40
  • S1 2,493.40
  • S2 2,471.70
  • S3 2,448.40

GlaxoSmithKline Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-11-03 Quarterly Results
2026-08-03 Quarterly Results
2026-05-13 Audited Results & Dividend
2026-02-09 Quarterly Results
2025-11-06 Quarterly Results
Date Purpose Remarks
2026-05-29 FINAL Rs.57.00 per share(570%)Final Dividend
2025-05-30 FINAL Rs.42.00 per share(420%)Final Dividend
2024-11-07 INTERIM Rs.12.00 per share(120%)Interim Dividend
2024-05-31 FINAL Rs.32.00 per share(320%)Final Dividend
2023-06-30 FINAL Rs.32.00 per share(320%)Final Dividend
View GlaxoSmithKline Pharmaceuticals Dividend History Arrow

GlaxoSmithKline Pharmaceuticals Shareholding Pattern

75%
11.77%
6.07%
4.75%
2.4%

About GlaxoSmithKline Pharmaceuticals

GlaxoSmithKline Pharmaceuticals is engaged interalia, in the business of manufacturing, distributing and trading in pharmaceuticals. View More
  • NSE Symbol
  • GLAXO
  • BSE Symbol
  • 500660
  • ISIN
  • INE159A01016

Similar Stocks to GlaxoSmithKline Pharmaceuticals

GlaxoSmithKline Pharmaceuticals FAQs

GlaxoSmithKline Pharmaceuticals share price is ₹2,515 As on 30 October, 2026 | 00:31

The Market Cap of GlaxoSmithKline Pharmaceuticals is ₹42607.3 Cr As on 30 October, 2026 | 00:31

The P/E ratio of GlaxoSmithKline Pharmaceuticals is 39.9 As on 30 October, 2026 | 00:31

The PB ratio of GlaxoSmithKline Pharmaceuticals is 17 As on 30 October, 2026 | 00:31

The 52 week High & Low of GlaxoSmithKline Pharmaceuticals is ₹3120.7/₹2088.1 respectively As on 30 October, 2026 | 00:31

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23